A Hospital Based Survey on Lung Cancer Related-pain in Northern China

NCT03189277 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2017-06-16

No results posted yet for this study

Summary

This cross-sectional study, utilizing two sets of questionaire designed for patients and physicians respectively, aims at the epidemiology, the clinical features, and the current status of evaluation and management of lung cancer related pain in 20 participating hospitals in Northern China.

Conditions

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • Beijing Chest Hospital

    collaborator OTHER
  • 307 Hospital of PLA

    collaborator OTHER
  • Peking Union Medical College Hospital

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • Peking University First Hospital

    collaborator OTHER
  • The Hospital of Shunyi District Beijing

    collaborator UNKNOWN
  • Daxing Hospital Beijing

    collaborator UNKNOWN
  • Peking University Third Hospital Yanqing Hospital

    collaborator UNKNOWN
  • Tianjin Medical University Cancer Institute and Hospital

    collaborator OTHER
  • Tianjin Medical University General Hospital

    collaborator OTHER
  • Hebei Medical University Fourth Hospital

    collaborator OTHER
  • Henan Cancer Hospital

    collaborator OTHER_GOV
  • Shanxi Province Cancer Hospital

    collaborator OTHER
  • Inner Mongolia People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • 309th Hospital of Chinese People's Liberation Army

    collaborator OTHER
  • Chinese Academy of Medical Sciences

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2017-09-30
Completion
2017-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03189277 on ClinicalTrials.gov